Search results
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 44 minutes agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 2 hours agoIn the first quarter alone, the company began pivotal phase 3 trials with two still-experimental...
6 Dividend Darlings to Keep Your Portfolio Going Amid Choppy Market Action
Investing.com· 17 minutes agoInvestors need to look beyond the headline number before investing for dividends. While the...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 15 hours agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 3 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 23 hours agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 5 days agoInsights into Volume & Open Interest Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer ...
If You Can Only Buy One Value Stock in May, It Better Be One of These 3 Names
InvestorPlace via Yahoo Finance· 6 days agoEveryone loves discounts and that’s essentially what value stocks to buy represent. The difference,...
How To Earn $500 A Month From Pfizer Stock
Benzinga· 4 days agoShares of Pfizer Inc. PFE closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Obesity Drug Stocks: Where to Invest Now
Morningstar· 7 days agoThe challenge is that both stocks currently trade in overvalued territory, according to Morningstar analysts. “We think current share prices do not...